allinaire therapeutics logo

Allinaire Therapeutics

At Allinaire Therapeutics,it identified a novel target to halt the progression of Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.allinaire.com
Founded2015
Disease Focus
Development StageDiscovery
STOCK CODENon Listed
Address
BioMotiv 20600 Chagrin Boulevard, Suite 210, OH-44122
Cleveland
United States
Email
Contact Number
+2164553200

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]